Hotaling Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,722
Closed -$2.22M 114
2020
Q3
$2.22M Buy
8,722
+270
+3% +$66.9K 1.2% 27
2020
Q2
$1.99M Sell
8,452
-27
-0.3% -$6.16K 1.15% 27
2020
Q1
$1.72M Buy
8,479
+139
+2% +$30.4K 1.28% 25
2019
Q4
$2.01M Buy
8,340
+106
+1% +$23.4K 1.15% 29
2019
Q3
$1.59M Buy
8,234
+235
+3% +$45.1K 1.02% 37
2019
Q2
$1.47M Sell
7,999
-5,771
-42% -$1.03M 0.95% 39
2019
Q1
$2.62M Buy
13,770
+245
+2% +$46.8K 1.77% 16
2018
Q4
$2.63M Buy
+13,525
New +$2.64M 2.14% 8

Other funds holding AMGN

Hotaling Investment Management's AMGN Position: Q4 2020 in Review

Hotaling Investment Management sold out of Amgen (AMGN) in Q4 2020, closing a stake of 8,722 shares — an estimated $2.22M sold.

Hotaling Investment Management first reported a position in AMGN in Q4 2018 and held it in 8 quarters. The position peaked at $2.63M in Q4 2018. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Hotaling Investment Management reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Hotaling Investment Management sold 8,722 Amgen shares in Q4 2020, an estimated $2.22M.
  • Hotaling Investment Management first reported a position in Amgen in Q4 2018 and held it in 8 quarters.
  • Hotaling Investment Management's Amgen position peaked at $2.63M in Q4 2018.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Hotaling Investment Management's 13F filing for Q4 2020, filed 22 Jan 2021.